Top broker tips another 28% upside for the Allkem (ASX: AKE) share price

Could analysts be right on this one?

| More on:
A miner in a hardhat makes a sale on his tablet in the field.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Allkem shares have struggled so far in 2022 and are down 7% 
  • Not all are downbeat on the stock with one firm remaining bullish on the company
  • In the last 12 months, the Allkem share price has surged 114%. 

The Allkem Ltd (ASX: AKE) share price is gaining quietly today and, at the time of writing, is 0.36% higher at $9.735.

After a solid period last year, the Allkem share price is struggling in 2022, down 7% this year to date.

However, one broker is heavily bullish on the lithium company and reckons there's plenty more upside potential for investors to bite into.

TradingView Chart

Can Allkem climb another 28% this year?

Analysts at Swiss investment bank UBS expect Allkem to deliver a strong result this year that should bode well for its share price.

The broker reckons Allkem will secure higher pricing for its lithium products and this should translate to higher earnings in 2022.

Considering that spodumene and lithium prices have soared 63% and 85% respectively this year already, the broker notes Allkem's earnings should benefit.

Further, the company's guidance on lithium carbonate pricing is for US$25,000 per tonne, a step ahead of the UBS forecast of US$23,000 a tonne.

This comes as Allkem renegotiated a one-third split in prices for its long-term carbonate contracts. This could lead to a phasing out of fixed prices.

UBS notes that Allkem's "realisation is improving structurally" and that "spot prices are maintaining particularly high levels, which is likely to see strong upward moves in Allkem's realised prices through the year".

The Swiss broker is bullish on Allkem, rating it a buy and valuing the company at $12.40 per share. That signals a 28% upside potential at the time of writing.

Meanwhile, the bulk of analysts covering Allkem also have it as a buy with more than 83% of brokers urging their clients to purchase the stock, according to Bloomberg Intelligence. The consensus price target is $13.55.

This is substantially higher than for the same time last year. Then only 46% of analysts were saying to buy the stock and 7% were advising to sell.

As of today, there are no brokers advocating to sell Allkem, according to Bloomberg.

Allkem share price snapshot

In the last 12 months, the Allkem share price has surged more than 114% but has faltered almost 7% this year to date.

During the past month though, the company's shares have reversed course after adding almost 11% in gains during the past week of trading.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Goldman Sachs says these ASX 200 stocks are strong buys

The broker is feeling very bullish about these stocks. But why?

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Bell Potter names more of the best ASX 200 stocks to buy in May

These stocks could be best buys this month according to the broker.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Man looking upwards contemplating which shares to buy
Broker Notes

CSL shares have climbed 10% since 11 April. Is it too late to buy?

What are analysts saying about this biotech giant after its recent rally? Let's find out.

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in May

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »